| Product Code: ETC9954264 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Seasonal Influenza Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Seasonal Influenza Market - Industry Life Cycle |
3.4 United Kingdom (UK) Seasonal Influenza Market - Porter's Five Forces |
3.5 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Seasonal Influenza Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about the importance of influenza vaccination |
4.2.2 Government initiatives and campaigns to promote flu vaccination |
4.2.3 Growing elderly population and increased susceptibility to flu |
4.2.4 Technological advancements in vaccine development and manufacturing processes |
4.3 Market Restraints |
4.3.1 Seasonal nature of influenza leading to fluctuating demand for vaccines |
4.3.2 Vaccine efficacy and effectiveness concerns |
4.3.3 Competition from alternative treatments or preventive measures |
4.3.4 Regulatory challenges and approval process for new vaccines |
5 United Kingdom (UK) Seasonal Influenza Market Trends |
6 United Kingdom (UK) Seasonal Influenza Market, By Types |
6.1 United Kingdom (UK) Seasonal Influenza Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Influenza A Viruses, 2021- 2031F |
6.1.4 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Influenza B Viruses, 2021- 2031F |
6.1.5 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Influenza C Virus, 2021- 2031F |
6.1.6 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Influenza D Viruses, 2021- 2031F |
6.1.7 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Seasonal Influenza Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Antiviral, 2021- 2031F |
6.2.3 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Neuraminidase Inhibitors, 2021- 2031F |
6.2.4 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.5 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Seasonal Influenza Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Seasonal Influenza Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Seasonal Influenza Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United Kingdom (UK) Seasonal Influenza Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Seasonal Influenza Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Seasonal Influenza Market Export to Major Countries |
7.2 United Kingdom (UK) Seasonal Influenza Market Imports from Major Countries |
8 United Kingdom (UK) Seasonal Influenza Market Key Performance Indicators |
8.1 Percentage increase in flu vaccination coverage rates among high-risk populations |
8.2 Number of flu-related hospitalizations and deaths prevented by vaccination |
8.3 Adoption rate of new influenza vaccine technologies |
8.4 Percentage of the population receiving flu vaccinations through government programs |
8.5 Rate of vaccine wastage and efficiency in distribution channels |
9 United Kingdom (UK) Seasonal Influenza Market - Opportunity Assessment |
9.1 United Kingdom (UK) Seasonal Influenza Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Seasonal Influenza Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Kingdom (UK) Seasonal Influenza Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Seasonal Influenza Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United Kingdom (UK) Seasonal Influenza Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Seasonal Influenza Market - Competitive Landscape |
10.1 United Kingdom (UK) Seasonal Influenza Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Seasonal Influenza Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here